Company intelligence / Profile preview
Mabqi
- Ownership
- Private
- Development stage
- Preclinical
Overview
Mabqi has developed a robust pipeline of innovative therapeutic antibodies targeting high unmet needs in oncology. Their platform enables rapid discovery and optimization of fully human functional drug candidates. Lead assets include unique pH-sensitive features and are convertible to next-generation formats such as ADCs, TCEs, or CAR-T therapies. Recent €5 million funding supports advancement of their lead program MQI‑201[5]. Some assets are available for partnership/licensing.
- Therapeutic areas
- Oncology
- Modalities
- Fully human monoclonal antibodies (mAbs)Multispecific antibodiesConditionally active pH-dependent antibodiesAntibody-drug conjugates (ADCs)T-cell engagers (TCEs)CAR-T therapies (convertible leads)
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Mabqi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mabqi.